Creso Pharma Limited
Creso Pharma Limited (COPHF) Revenue
Annual & quarterly revenue history · segment & region breakdown
COPHF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsCreso Pharma Limited trailing twelve-month (TTM) revenue is $0.03B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Creso Pharma Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Creso Pharma Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Creso Pharma Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
COPHF revenue · 4 questionsCOPHF's trailing twelve-month (TTM) revenue is $0.03B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Creso Pharma Limited SEC filings · GAAP · Creso Pharma Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026